Literature DB >> 1640799

Effects of chronic morphine on biliary tract responses to cholecystokinin-octapeptide in male guinea pigs.

A Malave1, G K Yim.   

Abstract

Opioid peptides share the spasmogenic action of acutely administered morphine on the sphincter of Oddi. In this study, gallbladder function was assessed following chronic opioid administration. Implantation of morphine pellets (400 mg) in male guinea pigs depressed cholecystokinin-octapeptide(CCK)-induced emptying of gallbladder bile (monitored via a duodenal cannula). Gallbladder muscle strips, isolated from the morphine treated animals, showed depressed contractile responses to CCK. This antagonism was non-specific and indirectly mediated, as ACh contractions were also depressed, whereas CCK-induced contractions of gallbladder strips from untreated animals were unaffected by direct exposure to morphine (3 x 10(-6)M). The depression of CCK stimulation of bile flow by chronic morphine administration in male guinea pigs suggests that chronic exposure to opioids can impede gallbladder emptying.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640799     DOI: 10.1016/0024-3205(92)90028-n

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Prospective sonographic evaluation of fentanyl side effects on the neonatal gallbladder.

Authors:  Beate Schmidt; Bernhard Roth; Hartmut Stützer; Gabriele Benz-Bohm
Journal:  Eur J Clin Pharmacol       Date:  2006-07-29       Impact factor: 2.953

2.  Somatic electrical nerve stimulation regulates the motility of sphincter of Oddi in rabbits and cats: evidence for a somatovisceral reflex mediated by cholecystokinin.

Authors:  J H Chiu; Y L Kuo; W Y Lui; C W Wu; C Y Hong
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

3.  Gall bladder contractility in neonates: effects of parenteral and enteral feeding.

Authors:  G Jawaheer; A Pierro; D A Lloyd; N J Shaw
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-05       Impact factor: 5.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.